Lexeo Therapeutics Inc (NASDAQ: LXEO) kicked off on Friday, up 3.97% from the previous trading day, before settling in for the closing price of $6.04. Over the past 52 weeks, LXEO has traded in a range of $5.77-$22.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.69%. While this was happening, its average annual earnings per share was recorded 74.84%. With a float of $23.81 million, this company’s outstanding shares have now reached $33.06 million.
Let’s determine the extent of company efficiency that accounts for 58 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Lexeo Therapeutics Inc (LXEO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Lexeo Therapeutics Inc is 28.00%, while institutional ownership is 73.91%. The most recent insider transaction that took place on Dec 10 ’24, was worth 20,491. In this transaction Chief Executive Officer of this company sold 2,500 shares at a rate of $8.20, taking the stock ownership to the 120,695 shares. Before that another transaction happened on Dec 10 ’24, when Company’s Director proposed sale 2,500 for $8.24, making the entire transaction worth $20,600.
Lexeo Therapeutics Inc (LXEO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.8 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.84% per share during the next fiscal year.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Take a look at Lexeo Therapeutics Inc’s (LXEO) current performance indicators. Last quarter, stock had a quick ratio of 5.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.84, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Looking closely at Lexeo Therapeutics Inc (NASDAQ: LXEO), its last 5-days average volume was 0.26 million, which is a jump from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 8.35%. Additionally, its Average True Range was 0.69.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 6.49%, which indicates a significant decrease from 17.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.62% in the past 14 days, which was higher than the 89.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.92, while its 200-day Moving Average is $11.86. However, in the short run, Lexeo Therapeutics Inc’s stock first resistance to watch stands at $6.48. Second resistance stands at $6.67. The third major resistance level sits at $7.01. If the price goes on to break the first support level at $5.95, it is likely to go to the next support level at $5.61. Should the price break the second support level, the third support level stands at $5.42.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
The company with the Market Capitalisation of 215.90 million has total of 33,066K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -66,390 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -29,490 K.
